Caplin Point Laboratories Limited

Caplin Point Laboratories Limited (CAPLIPOINT) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

caplinpoint.net(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-02

Stock price
₹2720.50
Market cap
20,683 Cr
Stock P/E
30.3
P/B
5.70
Dividend yield
0.2%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales410 Cr436 Cr453 Cr459 Cr483 Cr493 Cr502 Cr510 Cr534 Cr543 Cr600 Cr610 Cr
Operating expenses (approx.)273 Cr293 Cr308 Cr307 Cr318 Cr331 Cr334 Cr332 Cr345 Cr353 Cr396 Cr397 Cr
EBITDA137 Cr142 Cr145 Cr152 Cr165 Cr162 Cr168 Cr178 Cr189 Cr190 Cr204 Cr213 Cr
OPM %33.5%32.7%32.0%33.1%34.1%32.9%33.4%34.8%35.4%34.9%34.0%35.0%
Other income20 Cr17 Cr17 Cr19 Cr21 Cr31 Cr26 Cr23 Cr30 Cr34 Cr28 Cr34 Cr
Interest0.18 Cr0.17 Cr0.15 Cr0.05 Cr0.21 Cr0.18 Cr0.17 Cr0.18 Cr0.16 Cr0.18 Cr0.36 Cr0.18 Cr
Depreciation12 Cr14 Cr16 Cr16 Cr17 Cr16 Cr17 Cr16 Cr18 Cr19 Cr19 Cr22 Cr
Profit before tax146 Cr145 Cr146 Cr154 Cr168 Cr177 Cr177 Cr184 Cr201 Cr204 Cr213 Cr225 Cr
Tax %20.5%17.6%17.0%19.1%22.3%21.0%17.8%18.3%20.3%18.7%19.0%20.5%
Net profit116 Cr120 Cr121 Cr125 Cr131 Cr140 Cr145 Cr151 Cr160 Cr166 Cr173 Cr179 Cr
EPS (₹)₹15.13₹15.44₹16.01₹16.32₹17.22₹18.28₹18.75₹20.10₹20.32₹21.56₹22.38₹23.27

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales649 Cr863 Cr1,061 Cr1,269 Cr1,467 Cr1,694 Cr1,937 Cr2,187 CrSign in for TTM
Operating expenses (approx.)417 Cr603 Cr733 Cr875 Cr1,026 Cr1,143 Cr1,291 Cr1,426 CrSign in for TTM
EBITDA231 Cr260 Cr329 Cr395 Cr441 Cr551 Cr647 Cr761 CrSign in for TTM
OPM %35.7%30.1%31.0%31.1%30.1%32.6%33.4%34.8%Sign in for TTM
Other income19 Cr41 Cr24 Cr39 Cr56 Cr67 Cr96 Cr116 CrSign in for TTM
Interest0.06 Cr0.32 Cr2 Cr0.70 Cr0.78 Cr0.78 Cr0.61 Cr0.87 CrSign in for TTM
Depreciation23 Cr32 Cr37 Cr47 Cr45 Cr53 Cr66 Cr73 CrSign in for TTM
Profit before tax227 Cr269 Cr314 Cr386 Cr451 Cr564 Cr677 Cr803 CrSign in for TTM
Tax %22.2%20.2%19.8%20.1%16.5%18.3%20.0%19.1%Sign in for TTM
Net profit177 Cr215 Cr251 Cr308 Cr377 Cr461 Cr541 Cr650 CrSign in for TTM
EPS (₹)₹23.35₹28.42₹32.03₹39.61₹49.62₹60.19₹70.57₹84.36Sign in for TTM
Dividend payout %———7.4%8.0%7.4%7.0%7.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital15 Cr15 Cr15 Cr15 Cr15 Cr15 Cr15 Cr15 Cr
Reserves618 Cr858 Cr1,171 Cr1,469 Cr1,865 Cr2,301 Cr2,835 Cr3,571 Cr
Borrowings0.29 Cr—17 Cr0.50 Cr3 Cr1 Cr0.55 Cr0.57 Cr
Other liabilities109 Cr—143 Cr226 Cr281 Cr349 Cr322 Cr414 Cr
Total liabilities743 Cr—1,364 Cr1,736 Cr2,191 Cr2,697 Cr3,209 Cr4,045 Cr
Fixed assets (net)225 Cr—297 Cr277 Cr267 Cr439 Cr530 Cr547 Cr
CWIP10 Cr—14 Cr15 Cr220 Cr117 Cr139 Cr209 Cr
Investments70 Cr—11 Cr89 Cr230 Cr376 Cr590 Cr859 Cr
Loans & advances73 Cr—99 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Inventories37 Cr—179 Cr227 Cr288 Cr363 Cr336 Cr429 Cr
Trade receivables160 Cr—279 Cr320 Cr394 Cr543 Cr632 Cr826 Cr
Cash & bank49 Cr—232 Cr151 Cr178 Cr139 Cr199 Cr94 Cr
Other assets119 Cr—253 Cr657 Cr614 Cr722 Cr781 Cr1,081 Cr
Total assets743 Cr—1,364 Cr1,736 Cr2,191 Cr2,697 Cr3,209 Cr4,045 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———337 Cr272 Cr311 Cr432 Cr523 Cr
Cash from investing———-271 Cr-218 Cr-313 Cr-335 Cr-582 Cr
Cash from financing———-41 Cr-28 Cr-38 Cr-38 Cr-46 Cr
Net cash flow———25 Cr27 Cr-39 Cr59 Cr-105 Cr
Free cash flow (OCF − Capex)———246 Cr78 Cr165 Cr241 Cr275 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019Mar 2020Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %35.8%30.9%26.6%25.6%23.7%24.1%23.5%22.1%
ROE %27.9%24.6%20.4%22.8%19.7%19.5%19.5%17.7%
Debtor days90—969298117119137
Inventory days143—502430470553492437
Days payable231—248309268319319302
Cash conversion cycle2—350213300351292273
Debt / equity0.00050.000.010.00030.00180.00050.00020.0002
Current ratio5.73—7.236.255.805.726.976.70
Net debt / EBITDA-0.210.000.000.00-0.39-0.25-0.31-0.12

Compare with peers

Loading peers…